Eagle PharmaceuticalsEGRX
13F holders, Q2 2024 (June 30)75holders −16
13new positions
30sold out
4famous investors
$5.60avg. 13F price*
At the end of Q2 2024, 75 institutions reported holding Eagle Pharmaceuticals Inc. (EGRX) in their 13F filings, down 16 from Q1 2024. 13 opened new positions and 30 sold out. The largest holders were Nantahala Capital Management, LLC ($11.0M), AIGH Capital Management LLC ($6.8M) and Citigroup Inc. ($5.6M). 4 famous investors held it, including Cliff Asness (0.0% of AQR Capital Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio).
- Company
- Eagle Pharmaceuticals Inc.
- CUSIP
- 269796108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $2.4M |
| Exits | 30 | $3.7M |
All 13F filers, Q1 2024 → Q2 2024: 2,216,821 shares bought and 2,757,568 shares sold, net −540,747 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 75 holders
| Nantahala Capital Management, LLC | 1.11% | Add +55.9% | 1,962,070 | $11.0M |
| AIGH Capital Management LLC | 3.31% | Add +2.1% | 1,211,509 | $6.8M |
| Citigroup Inc. | 0.01% | Add +36749.0% | 1,001,555 | $5.6M |
| AQR Capital Management | 0.01% | Reduce -20.7% | 696,797 | $3.9M |
| Vanguard Group Inc. | 0.00% | Reduce -11.9% | 564,396 | $3.2M |
| BlackRock Inc. | 0.00% | Reduce -60.7% | 352,762 | $2.0M |
| Bank of America Corp. | 0.00% | Add +0.0% | 325,519 | $1.8M |
| Morgan Stanley | 0.00% | Reduce -19.9% | 300,448 | $1.7M |
| LSV Asset Management | 0.00% | Reduce -11.6% | 295,388 | $1.7M |
| Renaissance Technologies | 0.00% | Reduce -26.8% | 244,250 | $1.4M |
| Two Sigma Advisers, LP | 0.00% | Reduce -4.9% | 224,817 | $1.3M |
| Marshall Wace, LLP | 0.00% | Reduce -24.1% | 195,475 | $1.1M |
| J. Goldman & Co LP | 0.04% | Reduce -26.1% | 191,111 | $1.1M |
| Assenagon Asset Management S.A. | 0.00% | No change | 185,337 | $1.0M |
| Perceptive Advisors LLC | 0.02% | New | 173,365 | $971K |
| D. E. Shaw & Co. | 0.00% | Reduce -22.2% | 171,008 | $958K |
| Millennium Management | 0.00% | Reduce -34.9% | 167,782 | $940K |
| Two Sigma Investments, LP | 0.00% | Reduce -18.0% | 133,944 | $750K |
| Los Angeles Capital Management LLC | 0.00% | Reduce -30.8% | 132,606 | $743K |
| RBF Capital, LLC | 0.04% | New | 128,087 | $717K |
| Tang Capital Management LLC | 0.07% | No change | 118,857 | $666K |
| Geode Capital Management, LLC | 0.00% | Reduce -53.4% | 108,004 | $605K |
| Northern Trust Corp. | 0.00% | Reduce -5.5% | 94,062 | $527K |
| Invesco Ltd. | 0.00% | Reduce -29.7% | 82,424 | $462K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -55.5% | 79,093 | $443K |
| Trexquant Investment LP | 0.00% | Reduce -40.8% | 52,953 | $297K |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -31.6% | 50,589 | $283K |
| DGS Capital Management, LLC | 0.08% | Reduce -20.1% | 49,489 | $277K |
| Deutsche Bank AG | 0.00% | No change | 48,800 | $273K |
| Royal Bank of Canada | 0.00% | Add +33.5% | 37,601 | $211K |
| State Street Corp. | 0.00% | Reduce -83.2% | 35,820 | $201K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 31,900 | $179K |
| PDT Partners, LLC | 0.02% | Add +10.9% | 30,011 | $168K |
| FMR LLC | 0.00% | Add +31.9% | 29,163 | $163K |
| Acadian Asset Management LLC | 0.00% | Reduce -49.7% | 26,390 | $147K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 25,812 | $145K |
| Bank of Montreal | 0.00% | Reduce -3.9% | 24,696 | $138K |
| BNP Paribas Financial Markets | 0.00% | Reduce -34.7% | 24,402 | $137K |
| Great Lakes Advisors, LLC | 0.00% | Add +108.2% | 23,622 | $132K |
| ADAR1 Capital Management, LLC | 0.02% | New | 22,000 | $123K |
| XTX Topco Ltd | 0.01% | New | 20,204 | $113K |
| Barclays PLC | 0.00% | Reduce -15.4% | 19,109 | $107K |
| Squarepoint Ops LLC | 0.00% | New | 17,825 | $100K |
| Qube Research & Technologies Ltd | 0.00% | Add +372.1% | 16,763 | $94K |
| Royce & Associates LP | 0.00% | No change | 13,821 | $77K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | New | 13,629 | $76K |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -15.5% | 13,300 | $75K |
| Blair William & Co. | 0.00% | Reduce -7.4% | 13,100 | $73K |
| Jump Financial, LLC | 0.00% | Reduce -40.6% | 12,190 | $68K |
| Stanley-Laman Group, Ltd. | 0.01% | No change | 12,000 | $67K |
| HSBC Holdings PLC | 0.00% | Reduce -0.2% | 13,148 | $66K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | New | 11,612 | $65K |
| AJOVista, LLC | 0.18% | No change | 11,232 | $63K |
| Mackenzie Financial Corp. | 0.00% | New | 10,786 | $60K |
| Sei Investments Co. | 0.00% | Reduce -0.6% | 10,076 | $56K |
| Russell Investments Group, Ltd. | 0.00% | Add +323.8% | 9,798 | $55K |
| Fidelis Capital Partners, LLC | 0.01% | New | 12,762 | $54K |
| State of Wyoming | 0.01% | Reduce -62.5% | 8,118 | $45K |
| Rhumbline Advisers | 0.00% | Reduce -57.8% | 7,246 | $41K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | — | 4,881 | $27K |
| WealthCollab, LLC | 0.02% | Reduce -17.2% | 4,375 | $25K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -9.9% | 3,196 | $18K |
| JPMorgan Chase & Co. | 0.00% | Reduce -96.0% | 2,317 | $13K |
| Cwm, LLC | 0.00% | Reduce -25.3% | 1,672 | $9K |
| Osaic Holdings, Inc. | 0.00% | Add +333.1% | 719 | $4K |
| Macquarie Group Ltd. | 0.00% | New | 518 | $3K |
| UBS Group AG | 0.00% | Reduce -96.0% | 482 | $3K |
| Wells Fargo & Company | 0.00% | Reduce -91.2% | 351 | $2K |
| Archer Investment Corp | 0.00% | No change | 350 | $2K |
| Capital Advisors, Ltd. LLC | 0.00% | Reduce -14.9% | 149 | $1K |
| New York State Common Retirement Fund | 0.00% | Reduce -98.6% | 90 | $504 |
| Farther Finance Advisors, LLC | 0.00% | Reduce -27.3% | 64 | $354 |
| Global Retirement Partners, LLC | 0.00% | New | 49 | $274 |
| Front Row Advisors LLC | 0.00% | No change | 40 | $224 |
| PNC Financial Services Group, Inc. | 0.00% | New | 28 | $157 |
"% of holder's portfolio" is EGRX's weight in each manager's 13F, not the share of Eagle Pharmaceuticals Inc. the manager owns.